This article provides a comprehensive analysis of cryopreserving mesenchymal stromal/stem cells (MSCs) expanded in human platelet lysate (PL), a defined xeno-free alternative to fetal bovine serum (FBS).
Cryopreservation is essential for providing off-the-shelf mesenchymal stromal cell (MSC) therapies, but the freeze-thaw process significantly impairs cellular function, potentially compromising therapeutic efficacy.
The transition of allogeneic Mesenchymal Stromal Cell (MSC) therapies from research to clinical practice hinges on robust cryopreservation protocols that ensure cell viability, functionality, and therapeutic potency upon thawing.
This comprehensive review addresses the critical process of cryopreserving mesenchymal stem cell (MSC)-based tissue-engineered structures, a pivotal step for clinical translation in regenerative medicine.
This article provides a comprehensive guide to the slow freezing cryopreservation of Adipose-Derived Stem Cells (ADSCs), a critical process for their use in research and clinical therapies.
This comprehensive review synthesizes current research on the metabolic and functional consequences of cryopreservation on Mesenchymal Stromal Cells (MSCs), a critical consideration for clinical and research applications.
The move to DMSO-free cryopreservation is a critical advancement for the safety and efficacy of mesenchymal stem cell (MSC) therapies.
This comprehensive article provides researchers, scientists, and drug development professionals with an in-depth examination of Mesenchymal Stromal Cell (MSC) biobanking and cryostorage.
This article provides a systematic review of the critical role cryoprotectants play in the cryopreservation of Mesenchymal Stromal/Stem Cells (MSCs) for therapeutic applications.
The cryopreservation and subsequent thawing of Mesenchymal Stromal Cells (MSCs) are critical, yet potentially damaging, steps in the manufacturing of cell-based therapies.